BlueRock Therapeutics phase I clinical trial for Parkinson’s disease

[Farooqji]

“We are on the leading edge in the research for new treatment options for Parkinson’s disease as bemdaneprocel, the most clinically advanced pluripotent stem derived cell therapy candidate to date for this disease, continues to show positive trends,” said Christian Rommel, Member of the Executive Committee of Bayer’s Pharmaceuticals Division and Head of Research and Development. “There are good reasons to be optimistic about these early data, and we are excited to move to phase II later this year.”

finance.yahoo.com/news/blue...

[Obiora]

This has the potential to eliminate or heavily reduce the motor component of the disease.

We should have definite results in 5/7 years and have it clinically avaiable in 7/10 years, im really optimistix about the feasibility

[Ctime]

Does anyone know how they are recruiting for Phase 2? I thought I had read that they were pre approving people some how.